Cortechs.ai | Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye

Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye

Cortechs.ai CEO Kyle Frye Featured on SCALE Community Healthcare Technology & Innovation Podcast

We’re excited to share that Kyle Frye, CEO of Cortechs.ai, recently sat down with the SCALE Community Healthcare Technology & Innovation Podcast for an insightful conversation about the future of medical technology. As a market leader and innovator in AI-powered solutions for neurology, radiology, and oncology, Cortechs.ai is transforming healthcare through advanced imaging technologies.

In this episode, Kyle dives into how Cortechs.ai leverages clinical data and machine learning to empower physicians with more accurate and timely diagnostic insights. Listeners will hear about the company’s pioneering advancements, such as their state-of-the-art imaging solutions that improve patient outcomes and streamline clinical workflows.

Key topics discussed include:

  • The impact of AI-powered quantitative MRI in transforming radiology
  • Innovative solutions for neuroimaging and prostate cancer diagnosis
  • How data-driven insights are revolutionizing the decision-making process for physicians
  • The company’s vision for continued innovation in healthcare technology

Don’t miss this engaging conversation with Kyle as he shares how Cortechs.ai is shaping the future of medical imaging and empowering healthcare professionals worldwide.

You can listen to the podcast on:

Tune in to discover how Cortechs.ai is advancing clinical care through cutting-edge technology!

More Resources

10/29/2025

Enhancing Brain Tumor Treatment with RT STRUCT Images: The Promise of Automation

Automating the generation of RT STRUCT images with NeuroQuant Brain Tumor can streamline workflows and elevate the standard of care

10/15/2025

Sharper Screening, Smarter Biopsies: OnQ Prostate and the Next Step in Imaging

Read to learn how OnQ Prostate goes beyond existing solutions like DynaCAD and redefines biopsy precision

10/14/2025

Cortechs.ai Acquires ZepMed to Expand AI-Powered Neuroimaging Capabilities

This strategic acquisition strengthens Cortechs.ai’s position at the forefront of radiological innovation and expands its suite of best-in-class solutions

10/07/2025

Cortechs.ai Expands Partnership with Strategic Radiology to Advance Imaging Innovation Across Private Practices

Cortechs.ai and Strategic Radiology have now broadened their alliance to include Cortechs.ai’s full suite of imaging solutions.

10/06/2025

Clinical Performance of NeuroQuant: Transforming Brain MRI Analysis

NeuroQuant has consistently demonstrated strong clinical performance across multiple conditions, including Alzheimer’s , epilepsy, TBI, and MS.

10/02/2025

WEBINAR: Navigating Category III CPT Codes for Quantitative Imaging

Leveraging Compatible CPT Codes for NeuroQuant and OnQ Prostate
Scroll to Top